Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,537Revenue (TTM) $M2,506Net Margin (%)13.8Altman Z-Score0.8
Enterprise Value $M7,266EPS (TTM) $3.9Operating Margin %7.3Piotroski F-Score5
P/E(ttm)10.6Beneish M-Score-2.3Pre-tax Margin (%)-1.0Higher ROA y-yY
Price/Book2.410-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsN
Price/Sales1.45-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow62.5y-y EBITDA Growth Rate %8.7ROA % (ttm)5.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)16.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.3ROIC % (ttm)2.3Gross Margin Increase y-yN

Gurus Latest Trades with ALR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALRJohn Keeley 2016-03-31 Reduce-0.31%$35.47 - $54.11
($47.67)
$ 41.00-14%Reduce -26.02%713,314
ALRMario Gabelli 2016-03-31 Add0.08%$35.47 - $54.11
($47.67)
$ 41.00-14%Add 109.87%494,105
ALRGeorge Soros 2016-03-31 Buy 0.06%$35.47 - $54.11
($47.67)
$ 41.00-14%New holding42,800
ALRPrivate Capital 2016-03-31 Add0.02%$35.47 - $54.11
($47.67)
$ 41.00-14%Add 0.34%933,725
ALRPrivate Capital 2015-12-31 Reduce-0.06%$38.21 - $50.57
($42.74)
$ 41.00-4%Reduce -1.20%930,548
ALRJohn Keeley 2015-12-31 Reduce-0.01%$38.21 - $50.57
($42.74)
$ 41.00-4%Reduce -1.01%964,189
ALRMario Gabelli 2015-12-31 Add$38.21 - $50.57
($42.74)
$ 41.00-4%Add 0.86%235,430
ALRJohn Keeley 2015-09-30 Reduce-0.09%$45.76 - $55.39
($51.83)
$ 41.00-21%Reduce -6.81%974,047
ALRPrivate Capital 2015-09-30 Add0.08%$45.76 - $55.39
($51.83)
$ 41.00-21%Add 1.59%941,823
ALRMario Gabelli 2015-09-30 Add$45.76 - $55.39
($51.83)
$ 41.00-21%Add 6.88%233,430
ALRJohn Keeley 2015-06-30 Reduce-0.2%$47.48 - $52.75
($50.3)
$ 41.00-18%Reduce -15.76%1,045,227
ALRPrivate Capital 2015-06-30 Add0.09%$47.48 - $52.75
($50.3)
$ 41.00-18%Add 1.74%927,113
ALRMario Gabelli 2015-06-30 Add$47.48 - $52.75
($50.3)
$ 41.00-18%Add 4.92%218,400
ALRJoel Greenblatt 2015-03-31 Sold Out -0.12%$36.72 - $49.06
($43.88)
$ 41.00-7%Sold Out0
ALRJohn Keeley 2015-03-31 Reduce-0.08%$36.72 - $49.06
($43.88)
$ 41.00-7%Reduce -8.03%1,240,717
ALRPrivate Capital 2015-03-31 Add0.05%$36.72 - $49.06
($43.88)
$ 41.00-7%Add 1.00%911,238
ALRMario Gabelli 2015-03-31 Add$36.72 - $49.06
($43.88)
$ 41.00-7%Add 2.49%208,150
ALRJoel Greenblatt 2014-12-31 Buy 0.12%$36.31 - $40.2
($38.6)
$ 41.006%New holding382,075
ALRMario Gabelli 2014-12-31 Reduce-0.01%$36.31 - $40.2
($38.57)
$ 41.006%Reduce -23.00%203,100
ALRJoel Greenblatt 2014-09-30 Sold Out -0.01%$34.26 - $41.14
($37.35)
$ 41.0010%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Guerdan MelissaSVP, Global Quality & Reg. 2016-02-01Sell2,500$54-24.07view
Hargadon Robert BernardSVP, Global Human Resources 2015-11-13Buy1,000$38.995.16view
Hinrichs James F.Executive VP, CFO 2015-11-12Buy10,000$39.972.58view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-03Sell5,135$52-21.15view
Gladwell MarkSenior VP, Global Operations 2015-09-03Sell2,651$52.27-21.56view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-01Sell5,000$50.48-18.78view
Gladwell MarkSenior VP, Global Operations 2015-08-31Sell27,513$52.23-21.5view
Malkani SanjayGlobal Pres., Toxicology 2015-08-14Sell31,460$54.6-24.91view
Hinrichs James F.Executive VP, CFO 2015-08-07Buy20,000$49.33-16.89view
Malkani SanjayGlobal Pres., Toxicology 2015-06-08Sell24,331$50.87-19.4view

Press Releases about ALR :

Quarterly/Annual Reports about ALR:

News about ALR:

Articles On GuruFocus.com
Keeley Small Cap Value Fund 1st Quarter Commentary Apr 26 2016 
The Transformation in Alere May 22 2015 
Diamond Hill Capital Comments on Alere Inc Mar 17 2015 
Corsair Capital's Analysis of Alere Mar 06 2015 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
Mario Gabelli Comments on Alere Inc Nov 21 2014 
Mario Gabelli’s Asset Fund Q3 2014 Commentary Nov 21 2014 
Cohen Has Busy Third Quarter Nov 19 2014 
Diamond Hill Capital Comments on Alere Inc Oct 17 2014 

More From Other Websites
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... May 24 2016
Information on listing of individual pre-emptive rights to series I shares May 24 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alere Inc. of Class Action Lawsuit... May 23 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alere... May 20 2016
Class Action Lawsuits On Behalf of Investors of Alere Inc. Filed By Block & Leviton LLP May 20 2016
Registration of individual pre-emptive rights to series I shares in the securities deposit May 20 2016
Shareholder Class Action Filed Against Alere Inc. - ALR May 20 2016
The Polish Financial Supervision Authority decisions on including the proceeds from the issue of... May 20 2016
Ref: Current report as per art.113 item A letter j) of the National Securities Commission’s... May 20 2016
Entering into an underwriting agreement relating to series I shares May 18 2016
Approval of the prospectus for series I shares May 18 2016
INVESTOR ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against... May 17 2016
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Alere... May 17 2016
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal... May 16 2016
Alro reported an adjusted net profit of RON 41 million* in Q1 2016 May 16 2016
Shareholder Alert: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alere... May 13 2016
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Alere... May 13 2016
Communiqué regarding the availability of the financial results for Q1 2016 May 13 2016
Ref: Current Report in compliance with the Art.113 item A par. j) of the National Securities... May 13 2016
Current report prepared as per the provisions of art. 225 of Law no.297/2004 May 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)